Nature Communications · 2021 · 62 citations · 31 references
Veterinary MedicineImmunologyInfectious DiseasesEpidemiologyImmunizationVaccinologySeroprevalence StudiesVaccinationAttack RateInfection Risk FactorsLarge HouseholdsPopulation SerologyPopulation SerosurveysSars-cov-2 InfectionTransmission Risk FactorsViral Seroprevalence
The extent of SARS-CoV-2 circulation in many African countries remains unclear, underlining the need for antibody sero-surveys to assess the cumulative attack rate. Here, we present the results of a cross-sectional sero-survey of a random sample of residents of a health district in Yaounde, Cameroon, conducted from October 14 to November 26, 2020. Among the 971 participants, the test-adjusted seroprevalence of anti-SARS-CoV-2 IgG antibodies was 29·2% (95% CI 24·3-34·1). This is about 322 times greater than the 0.09% nationwide attack rate implied by COVID-19 case counts at the time. Men, obese individuals and those living in large households were significantly more likely to be seropositive, and the majority (64·2% [58·7-69·4]) of seropositive individuals reported no symptoms. Despite the high seroprevalence, most of the population had not been infected with SARS-CoV-2, highlighting the importance of continued measures to control viral spread and quick vaccine deployment to protect the vulnerable.
31
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Jennifer M. Dan, José Mateus, Yu Kato et al. · Science · 2021 · 3K citations · Full text
Analysis of Complex Survey Samples
Thomas Lumley · Journal of Statistical Software · 2004 · 2.3K citations · Full text